US Castration-Resistant Prostate Cancer Therapeutics Market: Emerging Treatment Innovations
The US castration-resistant prostate cancer therapeutics market is expanding with the continued development and adoption of advanced treatment options for patients whose disease progresses despite androgen-deprivation therapy. Hormonal therapies, androgen receptor pathway inhibitors, chemotherapy, radiopharmaceuticals, and biomarker-guided treatments are contributing to the evolving treatment...
0 Commenti 0 condivisioni 17 Views 0 Anteprima